These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26994242)

  • 1. Identification of variants of the ryanodine receptor type 1 in patients with exertional heat stroke and positive response to the malignant hyperthermia in vitro contracture test.
    Roux-Buisson N; Monnier N; Sagui E; Abriat A; Brosset C; Bendahan D; Kozak-Ribbens G; Gazzola S; Quesada JL; Foutrier-Morello C; Rendu J; Figarella-Branger D; Cozonne P; Aubert M; Bourdon L; Lunardi J; Fauré J
    Br J Anaesth; 2016 Apr; 116(4):566-8. PubMed ID: 26994242
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant hyperthermia and apparent heat stroke.
    Tobin JR; Jason DR; Challa VR; Nelson TE; Sambuughin N
    JAMA; 2001 Jul; 286(2):168-9. PubMed ID: 11448278
    [No Abstract]   [Full Text] [Related]  

  • 3. Exertional Heat Stroke and Susceptibility to Malignant Hyperthermia in an Athlete: Evidence for a Link?
    Poussel M; Guerci P; Kaminsky P; Heymonet M; Roux-Buisson N; Faure J; Fronzaroli E; Chenuel B
    J Athl Train; 2015 Nov; 50(11):1212-4. PubMed ID: 26565425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hyperthermia.
    Bouchama A; Hussain S
    Lancet; 1998 Nov; 352(9142):1785. PubMed ID: 9848381
    [No Abstract]   [Full Text] [Related]  

  • 5. Calsequestrin-1: a new candidate gene for malignant hyperthermia and exertional/environmental heat stroke.
    Protasi F; Paolini C; Dainese M
    J Physiol; 2009 Jul; 587(Pt 13):3095-100. PubMed ID: 19417098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the nature of the link between malignant hyperthermia and exertional heatstroke.
    Bourdon L; Canini F
    Med Hypotheses; 1995 Sep; 45(3):268-70. PubMed ID: 8569550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exertional heat illness.
    Porter AM
    J R Army Med Corps; 2002 Jun; 148(2):208. PubMed ID: 12174567
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignant hyperthermia and the clinical significance of type-1 ryanodine receptor gene (RYR1) variants: proceedings of the 2013 MHAUS Scientific Conference.
    Riazi S; Kraeva N; Muldoon SM; Dowling J; Ho C; Petre MA; Parness J; Dirksen RT; Rosenberg H
    Can J Anaesth; 2014 Nov; 61(11):1040-9. PubMed ID: 25189431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ryanodine contracture: a potentially specific in vitro diagnostic test for malignant hyperthermia.
    Hopkins PM; Ellis FR; Halsall PJ
    Br J Anaesth; 1991 May; 66(5):611-3. PubMed ID: 2031823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diseases associated with altered ryanodine receptor activity.
    Durham WJ; Wehrens XH; Sood S; Hamilton SL
    Subcell Biochem; 2007; 45():273-321. PubMed ID: 18193641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant Hyperthermia, Exertional Heat Illness, and RYR1 Variants: The Muscle May Not Be the Brain.
    Sagui E
    Anesthesiology; 2016 Feb; 124(2):510. PubMed ID: 26785433
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there a link between exertional heat stroke and susceptibility to malignant hyperthermia?
    Sagui E; Montigon C; Abriat A; Jouvion A; Duron-Martinaud S; Canini F; Zagnoli F; Bendahan D; Figarella-Branger D; Brégigeon M; Brosset C
    PLoS One; 2015; 10(8):e0135496. PubMed ID: 26258863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of malignant hyperthermia in patients carrying a variant in the skeletal muscle ryanodine receptor 1 gene.
    Janssens L; De Puydt J; Milazzo M; Symoens S; De Bleecker JL; Herdewyn S
    Neuromuscul Disord; 2022 Dec; 32(11-12):864-869. PubMed ID: 36283893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous occurrence of the disposition to malignant hyperthermia.
    Rueffert H; Olthoff D; Deutrich C
    Anesthesiology; 2004 Mar; 100(3):731-3. PubMed ID: 15108991
    [No Abstract]   [Full Text] [Related]  

  • 15. Exertional rhabdomyolysis and malignant hyperthermia in a patient with ryanodine receptor type 1 gene, L-type calcium channel alpha-1 subunit gene, and calsequestrin-1 gene polymorphisms.
    Capacchione JF; Sambuughin N; Bina S; Mulligan LP; Lawson TD; Muldoon SM
    Anesthesiology; 2010 Jan; 112(1):239-44. PubMed ID: 20010423
    [No Abstract]   [Full Text] [Related]  

  • 16. Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept.
    Riazi S; Kraeva N; Hopkins PM
    Anesthesiology; 2018 Jan; 128(1):168-180. PubMed ID: 28902675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.
    Roesl C; Sato K; Schiemann A; Pollock N; Stowell KM
    Cell Calcium; 2014 Sep; 56(3):195-201. PubMed ID: 25086907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a link between malignant hyperthermia and exertional heat illness?
    Muldoon S; Deuster P; Brandom B; Bunger R
    Exerc Sport Sci Rev; 2004 Oct; 32(4):174-9. PubMed ID: 15604937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant hyperthermia: a pharmacogenetic disorder.
    Stratman RC; Flynn JD; Hatton KW
    Orthopedics; 2009 Nov; 32(11):835. PubMed ID: 19902883
    [No Abstract]   [Full Text] [Related]  

  • 20. Continued progress in understanding the molecular genetics of malignant hyperthermia.
    Rosenberg H
    Can J Anaesth; 2011 Jun; 58(6):489-93. PubMed ID: 21455644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.